Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra K Newman

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Blood|September 5, 2009
PI3Kbeta goes to the head of its classDebra K Newman
Blood|June 27, 2015
CLEC-2: the inside storyDebra K Newman
Blood|September 29, 2018
G6b-B: the "Y's" and whereforesDebra K Newman
Blood|April 20, 2013
CD39 target practiceDebra K Newman
Human Immunology|November 9, 2024
Antigen-specific immunotherapy for platelet alloimmune disordersDebra K Newman, Peter J Newman
Blood|October 30, 2025
In pursuit of FNAIT biomarkers: αVβ3 specificity falls shortPeter J Newman, Debra K Newman
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2003
Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biologyPeter J Newman, Debra K Newman
Life Sciences|June 15, 2010
PECAM-1: conflicts of interest in inflammationJamie R Privratsky, Debra K Newman, Peter J Newman
Blood|July 26, 2022
Prophylactic administration of HPA-1a-specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in miceHuiying Zhi, Douglas Sheridan, Debra K Newman, et al.
FEBS Letters|August 26, 2004
Phospholipase Cgamma2 contributes to stable thrombus formation on VWFVipul Rathore, Demin Wang, Debra K Newman, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Blood|September 5, 2009
PI3Kbeta goes to the head of its classDebra K Newman
Blood|June 27, 2015
CLEC-2: the inside storyDebra K Newman
Blood|September 29, 2018
G6b-B: the "Y's" and whereforesDebra K Newman
Blood|April 20, 2013
CD39 target practiceDebra K Newman
Human Immunology|November 9, 2024
Antigen-specific immunotherapy for platelet alloimmune disordersDebra K Newman, Peter J Newman
Blood|October 30, 2025
In pursuit of FNAIT biomarkers: αVβ3 specificity falls shortPeter J Newman, Debra K Newman
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2003
Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biologyPeter J Newman, Debra K Newman
Life Sciences|June 15, 2010
PECAM-1: conflicts of interest in inflammationJamie R Privratsky, Debra K Newman, Peter J Newman
Blood|July 26, 2022
Prophylactic administration of HPA-1a-specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in miceHuiying Zhi, Douglas Sheridan, Debra K Newman, et al.
FEBS Letters|August 26, 2004
Phospholipase Cgamma2 contributes to stable thrombus formation on VWFVipul Rathore, Demin Wang, Debra K Newman, et al.
Pageof 7